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Abstract: Surgical and bronchoscopic lung volume reduction (LVR) have been demonstrated to improve
lung function, dyspnea and quality of life in patients with severe pulmonary emphysema. The most im-
portant functional prerequisite for a successful LVR is hyperinflation measured by body plethysmography.
A residual volume (RV) of more than 180% predicted and a RV/total lung capacity (TLC) ratio of more
than 0.58 were inclusion criteria in major LVR trials. Here we report a successful LVR in a 68-year-old
man with advanced, heterogeneous emphysema without plethysmographic evidence of severe hyperinfla-
tion (RV/TLC 0.45). Computed tomography (CT) revealed severe, partly bullous upper lobe emphysema
and subtle fibrotic changes with volume loss of lower lobes. Since lower lobes appeared compressed by
upper lobe emphysema, these target areas were removed by thoracoscopic LVR. Four months later, the
patient reported major improvements of dyspnea, FEV (by 1.27 L) and 6-minute walking distance (by
150 meters). LVR reduced total lung volume measured by CT-volumetry by 0.5 L and upper lobe vol-
ume by 1.85 L while lower lobe volume increased by +1.34 L. Low density volume (-950 HU) reflecting
emphysema was reduced by 1.73 L. We conclude that the opposing effects of emphysema and fibrosis
resulted in a barely increase in total lung volume that was only slightly reduced by LVR. Nevertheless,
resection of emphysematous target areas identified by quantitative CT analysis provided major clinical
and physiologic improvements related to decompression of low-compliance lower lobe areas retracted by
early fibrosis. Therefore, in the combined presence of severe, heterogeneously distributed emphysema and
fibrosis, LVR may improve respiratory mechanics even if RV/TLC, an established body-plethysmographic
predictor of LVR success is not severely elevated.
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Introduction
Chronic obstructive lung disease (COPD) is an irreversibly 
progressive disease with gradual decline of quality of life 
due to impaired physical performance. The World Health 
Organization expects the burden of COPD to increase in 
the next few years due to aging of the world population 
and to become the 4th leading cause of death in 2030 (1). 
The main causes for COPD are smoking and air pollution. 
Smoking cessation and oxygen therapy in hypoxemic 
patients are the only known conservative means to prolong 
life in affected patients. Inhaled medications and pulmonary 
rehabilitation can increase quality of life and reduce the rate 
of exacerbations. Hypercapnic patients may benefit from 
non-invasive ventilation (2).
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Abstract: Surgical and bronchoscopic lung volume reduction (LVR) have been demonstrated to improve 
lung function, dyspnea and quality of life in patients with severe pulmonary emphysema. The most 
important functional prerequisite for a successful LVR is hyperinflation measured by body plethysmography. 
A residual volume (RV) of more than 180% predicted and a RV/total lung capacity (TLC) ratio of more 
than 0.58 were inclusion criteria in major LVR trials. Here we report a successful LVR in a 68-year-old man 
with advanced, heterogeneous emphysema without plethysmographic evidence of severe hyperinflation 
(RV/TLC 0.45). Computed tomography (CT) revealed severe, partly bullous upper lobe emphysema and 
subtle fibrotic changes with volume loss of lower lobes. Since lower lobes appeared compressed by upper 
lobe emphysema, these target areas were removed by thoracoscopic LVR. Four months later, the patient 
reported major improvements of dyspnea, FEV1 (by 1.27 L) and 6-minute walking distance (by 150 meters). 
LVR reduced total lung volume measured by CT-volumetry by 0.5 L and upper lobe volume by 1.85 L while 
lower lobe volume increased by +1.34 L. Low density volume (−950 HU) reflecting emphysema was reduced 
by 1.73 L. We conclude that the opposing effects of emphysema and fibrosis resulted in a barely increase in 
total lung volume that was only slightly reduced by LVR. Nevertheless, resection of emphysematous target 
areas identified by quantitative CT analysis provided major clinical and physiologic improvements related to 
decompression of low-compliance lower lobe areas retracted by early fibrosis. Therefore, in the combined 
presence of severe, heterogeneously distributed emphysema and fibrosis, LVR may improve respiratory 
mechanics even if RV/TLC, an established body-plethysmographic predictor of LVR success is not severely 
elevated.
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Lung volume reduction (LVR)—both surgical or 
bronchoscopic—showed a benefit in quality of life and 
survival in multiple randomized trials in selected patients 
with severe airflow obstruction and hyperinflation (3-8). 
Usually, static hyperinflation is assessed with body 
plethysmography based on residual volume (RV) and RV/
total lung capacity (TLC) ratio (9). RV of more than 175% 
predicted and a RV/TLC ratio of more than 0.58 were 
main inclusion criteria in major studies (3-6,10-17). Both 
parameters are key features to qualify for a LVR (18,19), 
since the diaphragm has been demonstrated to gain strength 
after “deflation” of the lung (20). 
To the best of our knowledge, this is the first report on 
a successful surgical LVR in an emphysema patient without 
the conventional evidence of hyperinflation measured by 
body plethysmography. 
Case presentation
A 68-year-old patient was referred for evaluation of a LVR 
therapy. He was on inhaled bronchodilators [long-acting 
beta 2-agonist (LABA), long-acting muscarinic antagonist 
(LAMA)] and topical glucocorticoids, had participated in 
several pulmonary rehabilitation programs and was on 
long term oxygen therapy. Despite of all the therapies he 
still suffered from severe dyspnea on minimal exertion 
(e.g., after climbing more than one fleet of stairs), while 
he denied chronic cough and acute exacerbations. Due 
to his severely impaired exercise tolerance, he already 
mentioned early signs of social retreat and depression. At 
physical examination, the patient had a marked barrel-
like configuration of his thorax with slightly elevated 
shoulders suggesting clinical evidence of hyperinflation 
and pursed lip breathing during. Spirometry revealed 
severe airflow obstruction with an FEV1 of 42% predicted, 
and TLC and RV measured by body plethysmography 
were 122% predicted and 145% predicted, respectively 
(Table 1). Based on TLC, RV and the ratio of RV/TLC of 
0.45, there was no evidence of severe absolute or relative 
hyperinflation. The chest radiograph revealed signs of 
mild hyperinflation, an increased transparency of upper 
lobes and reticular changes in the lower lobes (Figure 1). 
Chest computed tomography (CT) showed a pronounced 
heterogeneity of the lung density. In particular, the right 
upper and middle lobes, and, to a lesser extent, also the 
left upper lobe, revealed partially bullous emphysematous 
destruction of the lung architecture, while the lower lobes 
were of much higher density suggesting some compression 
and early fibrotic changes in some areas (Figure 2). 
CT volumetry revealed a total lung volume of 8.01 L, 
Table 1 Pulmonary function before and after lung volume reduction surgery
Time
FVC (liters) 
[%predicted]
FEV1 (liters) 
[%predicted]
FEV1/FVC
TLC (liters) 
[%predicted]
RV (liters) 
[%predicted]
RV/TLC
TLCO 
[%predicted] 
6-MWD 
(meters)
Before LVRS 2.94 [80] 1.19 [42] 0.40 7.95 [122] 3.61 [145] 0.45 30 450
After LVRS
5 months po 5.16 [136] 2.46 [84] 0.47 7.97 [120] 2.48 [98] 0.31 36 600
12 months po 5.26 [139] 2.34 [81] 0.44 – – – – 568
18 months po 5.55 [147] 2.22 [77] 0.40 8.31 [125] 2.55 [100] 0.41 34 550
24 months po 4.75 [121] 1.98 [67] 0.42 – – – 34 –
FEV1, forced expiratory volume in one second; FVC, forced vital capacity; LVRS, lung volume reduction surgery; po, postoperative; RV, 
residual volume; TLC, total lung capacity; TLCO, transfer factor of the lung for carbon monoxide; 6-MWD, 6-minute walking distance.
Figure 1 Preoperative chest X-ray.
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Straub et al. LVRS in CPFE
Figure 2 Quantitative CT analysis. (A-D) show representative transverse and sagittal CT sections before (A,B) and 5 months after LVR (C,D). 
Bullous emphysematous changes are appreciated in the upper lobes while the lower lobes have an increased density and linear opacities. 
These alterations are pronounced before LVR and reduced after the intervention. (E-H) show the CT-volumetrically determined volumes 
of the upper and lower lobes before and after LVR (E,F) and the lung volume with very low density (−950 HU) considered to represent 
emphysema (G,H). LVR decreased upper lobe and increased lower lobe volumes by the amount indicated in the columns (values in liters). 
The decrease in the left and right lung volume (F, −1.85 liters) is nearly identical to the decrease in tissue of very low density (H, −1.96 liters) 
suggesting that virtually all resected volume was of very low density (emphysema). LVRS, lung volume reduction surgery.
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which was very similar to the TLC of 7.95 L measured by 
body plethysmography (Figure 2, Table 1). According to 
CT-volumetry, the volume of both upper lobes was 5.63 L, 
the volume of the middle and lower lobes, 3.38 L. The 
estimated emphysema volume based on lung zones with 
very low density below −950 HU was 3.38 L.
After interdisciplinary discussion with thoracic surgeons 
the decision was made to offer surgical LVR because of the 
obvious CT-radiological signs of regional hyperinflation and 
bullous lung destruction in combination with basal fibrosis. 
The patient was informed about the missing conventional 
inclusion criteria. Nevertheless, he fully agreed to 
undergo the procedure despite possible disadvantages or 
complications.
Thoracoscopic LVR of the most destructed areas of the 
right upper and middle lobes and of the left upper lobe was 
performed. There were no perioperative complications. 
Drainage time was 3 days. Only a few days after the 
operation the patient already perceived an improvement of 
dyspnea, and he could be dismissed from hospital on the 
4th postoperative day. Five months later, the patient was in 
markedly improved physical and psychological condition. 
His pulmonary function showed a marked increase in 
FEV1 by 107% (+1.27 L), no significant change in TLC 
(by body plethysmography), a decrease in RV by 1.13 L, 
and the 6-minute walking distance (6-MWD) improved 
by 150 meters (Table 1). Successful LVR was confirmed 
by quantitative CT analysis (Figure 2) suggesting a major 
reduction in upper lobe volume corresponding to areas 
destructed by emphysema, and a simultaneous increase in 
lower lobe volume. Lung function and 6-MWD gradually 
declined over the next 2 years, and the patient developed 
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progressive combined pulmonary fibrosis and emphysema 
(CPFE) with pulmonary artery hypertension [mean 
pulmonary artery pressure (mPAP) 59 mmHg]. 
Discussion
In severe pulmonary emphysema hyperinflation is assessed 
routinely by body plethysmography. Increased RV and 
RV/TLC are established predictors of successful LVR, 
independent of whether by surgery or by bronchoscopy (18). 
According to the described case, there might be a selected 
number of patients who benefit from LVR even though RV 
and RV/TLC, which are global measures of hyperinflation, 
are only moderately increased. In some of these highly 
selected patients pronounced regional hyperinflation 
evidenced by CT in combination with less affected areas 
or even areas with reduced lung compliance such as in 
pulmonary fibrosis may suggest the potential for a benefit 
from targeted LVR. An appealing explanation of the lack 
of plethysmographic evidence of significant hyperinflation 
in the described case is that total lung volume measured 
globally by plethysmography was only slightly elevated. 
Evidently, the pronounced hyperinflation of upper lobes 
and apical lower lobes was offset by volume loss in the lower 
lobes due compression and retraction by fibrosis. CT before 
LVR showed slight reticular opacities of both basal lung 
fields. Consistently, airflow obstruction and hyperinflation 
have been demonstrated to be counteracted by pulmonary 
fibrosis in cases of CPFE (21).
According to the CT-volumetric and densitometric 
analysis, the LVR reduced the total lung volume only 
mildly (by 0.5 L) but it confirmed removal of 1.85 L of 
upper lobe volume and reduction of emphysematous tissue 
by 1.96 L (Figure 2). This suggests that the surgeon was 
able to remove nearly exclusively emphysematous target 
areas. At the same time, the lower lobe volume increased 
significantly by 1.34 L (Figure 2) with virtually no increase 
in the very low density volume. This is consistent with no 
change in the amount of emphysema in the lower lobes that 
were rather dense due to early fibrosis. Therefore, LVR 
seemed to have reduced compression of the lower lobes that 
were subsequently expanded to a greater extent which may 
have contributed to improvement of airflow obstruction as 
suggested by an increase in FEV1 and FEV1/FVC. 
There is increasing evidence of the clinical importance of 
dynamic hyperinflation in patients with COPD (22). Dynamic 
hyperinflation might also explain the exercise limitation in the 
current patient before LVR. Expiratory collapse of the airways 
in areas of the lung with emphysematous destruction together 
with a reduced airway calibre due to progressive compression 
of the lower lobes due to increasing hyperinflation of the upper 
lobes during physical exertion might have exacerbated airflow 
obstruction. However, we could not verify this hypothesis 
in our patient because CT-volumetry during exercise is not 
feasible and repeated inspiratory capacity measurements that 
are performed to evaluate global dynamic hyperinflation would 
not have detected the relative volume changes in the upper and 
lower lobes.
Conclusions
Our observations demonstrate that in selected (rare) cases, 
LVR may provide a clinical and functional improvement in 
patients with emphysema even when established predictors 
of successful LVR such as elevations in TLC, RV and RV/
TLC are not pronounced. Quantitative CT analysis may 
identify regional hyperinflation due to emphysema in 
combination with reduced volume of lung regions with 
fibrotic changes such as in patients with CPFE that result 
in mutually opposing changes of lung volume. LVR of 
carefully targeted emphysematous areas of the lung may 
provide clinical and functional improvement in these 
particular conditions.
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